Key Highlights
•
A new study shows that vildagliptin, a common diabetes drug, protects brain cells in a mouse model of Parkinson’s disease by reducing inflammation and targeting key cell survival pathways.
Source →
•
This is important because it suggests that widely used diabetes medications like vildagliptin could be repurposed to fight neurodegenerative diseases, potentially offering a new treatment avenue for Parkinson’s patients.
Source →
•
A new study on dementia finds that the body’s 24-hour circadian clock is closely linked to levels of a key molecule called NAD+, and that both decline with the disease.
Source →
•
The review highlights that strategies like timed light exposure, exercise, and NAD+ supplements could help restore this rhythm, pointing to a promising way to improve sleep and slow cognitive decline in dementia patients.
Source →
•
A study from France has linked an outbreak of severe respiratory illness and death in older adults to Human Rhinovirus B14, showing that even a common cold virus can be dangerous for the elderly.
Source →
•
This finding is significant because it emphasizes the need for better monitoring and prevention of rhinovirus infections in nursing homes and other settings with vulnerable populations, especially those with underlying health conditions.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
